Tempur Sealy International Inc. (TPX) Financials Nov 18,
Tempur Sealy International Inc. (TPX) Financials Nov 18, 2014, 9:56 a.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Tempur Sealy International Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 831.16M 1.11B 1.42B 1.4B 2.46B
Cost of Goods Sold (COGS) incl. D&A 437.41M 549.99M 674.85M 688.3M 1.45B
COGS excluding D&A 405.99M 517.63M 640.55M 652M 1.37B
Depreciation & Amortization Expense 31.42M 32.36M 34.3M 36.3M 74.6M
Depreciation 29.01M 28M 28.92M 30.9M 59.4M
Amortization of Intangibles 2.41M 4.36M 5.38M 5.4M 15.2M
Gross Income 393.74M 555.43M 743.09M 714.6M 1.01B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 248.8M 309.53M 402.56M 466.3M 789.2M
Research & Development 6.46M 7.42M 9.91M - -
Other SG&A 242.34M 302.11M 392.65M 466.3M 789.2M
Other Operating Expense 0 0 0 0 0
Unusual Expense (728,000) 8.95M 509,000 3.2M -
EBIT after Unusual Expense 728,000 (8.95M) (509,000) (3.2M) -
Non Operating Income/Expense (287,000) 1.77M (1.13M) (300,000) 8.7M
Non-Operating Interest Income 0 - 0 0 0
Equity in Affiliates (Pretax) 0 0 0 - 4.4M
Interest Expense 17.35M 7.86M 10.5M 15.6M 110.8M
Gross Interest Expense 17.35M 7.86M 10.5M 15.6M 110.8M
Interest Capitalized 0 0 0 0 0
Pretax Income 128.04M 230.87M 328.39M 229.2M 128M
Income Tax 43.04M 73.72M 108.78M 122.4M 49.1M
Income Tax - Current Domestic 31.81M 47.95M 88.89M 57.7M 55.9M
Income Tax - Current Foreign 21.04M 25.27M 28.43M 26.3M 42.3M
Income Tax - Deferred Domestic (10.1M) 2.36M (1.59M) 41.3M (46.6M)
Income Tax - Deferred Foreign 285,000 (1.86M) (6.94M) (2.9M) (2.5M)
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 84.99M 157.15M 219.61M 106.8M 78.9M
Minority Interest Expense 0 0 0 0 300,000
Net Income 84.99M 157.15M 219.61M 106.8M 78.6M
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg - 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 84.99M 157.15M 219.61M 106.8M 78.6M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 84.99M 157.15M 219.61M 106.8M 78.6M
EPS (Basic) 1.13 2.23 3.27 1.74 1.30
Basic Shares Outstanding 74.93M 70.35M 67.07M 61.5M 60.3M
EPS (Diluted) 1.12 2.16 3.18 1.70 1.28
Diluted Shares Outstanding 76.05M 72.79M 69.15M 62.9M 61.6M
EBITDA 176.37M 278.26M 374.83M 284.6M 300.3M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...
Continue Reading
Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...
Continue Reading
Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...
Continue Reading
Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...
Continue Reading
Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...
Continue Reading
In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...
Continue Reading
The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...
Continue Reading
A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...
Continue Reading
The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...
Continue Reading
IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...
Continue Reading
Top 5 Most Recently Viewed Articles
Investors Urged to Take Action in Ibotta Class Action Lawsuit If you have invested in Ibotta, Inc. (NYSE: IBTA), it may be time to pay attention. Shareholders are being encouraged to take part in a class action lawsuit that seeks to address the alleged wrongdoings associated with the company's public offering. This initiative is spearheaded by The Gross Law Firm, which...
Continue Reading
Strategic Board Appointment at TOMI Environmental Solutions TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ), a key player in the realm of disinfection and decontamination technologies, recently announced an important addition to its Board of Directors. Harold W. Paul has been appointed to this role, a move that is expected to have a significant positive impact on the...
Continue Reading
MaxCyte Forms Strategic Alliance with Moonlight Bio MaxCyte, Inc. (Nasdaq: MXCT), a pioneering cell-engineering organization, has recently announced a significant collaborative effort with Moonlight Bio, a Seattle-based company focused on pioneering preclinical-stage T cell therapies. This partnership will leverage MaxCyte’s advanced technologies to propel the...
Continue Reading
Revolutionizing Drone Services and Defense Innovations VANCOUVER, British Columbia — ZenaTech, Inc. (NASDAQ: ZENA) (BMV: ZENA) (FSE: 49Q) stands at the forefront of technological solutions, focusing on the exciting realm of Drone as a Service (DaaS) as well as commercial drone developments catering to various industries. The company recently announced its participation...
Continue Reading
Lavu's CEO to Share Insights on AI and Payment Innovations Lavu, a trailblazer in restaurant AI platforms, is gearing up for an enlightening presentation featuring its CEO, Saleem S. Khatri. He will be a keynote speaker at an upcoming event focusing on the intersection of fintech, AI, and payment systems. A Discussion on Restaurant Operations and Payments The session,...
Continue Reading